US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals: market research reports

The pharmaceutical industry is a $1 trillion-dollar sector and has been a major engine of economic growth and scientific advancement for decades. The industry encompasses a wide range of enterprises including large ethical drug multi-nationals (so-called Big Pharma), mid-sized specialty pharmaceutical companies, generic manufacturers, virtual pharmas, small biotechnology and biopharmaceutical firms, and all the various ancillary support and service companies that provide contract research, regulatory guidance, contract sales, and manufacturing technologies and raw materials.

Although growth has not been as robust in recent years—mainly due to price pressures, uncertainty in regulatory/reform measures, and weak drug pipelines— the demographic and structural drivers of demand in healthcare still exist: namely, the continued aging of the global population and the increasing sophistication and wealth of developing nations. Shifting epidemiology patterns and outbreaks, along with new challenges in chronic disease, cancer, heart disease, and degenerative disease will continue to impel the need for ever-better medicines. New understanding and technologies in drug delivery, and most especially in the fields of genomics, proteomics, and molecular biology generally, also hold promise for better therapeutics and a revival of profits.

  • Biopharmaceuticals (286)
  • Diseases & Conditions (3812)
  • Drug Delivery (293)
  • Therapeutic Area (7263)
  • Vaccines (727)
RSS Feeds

Pharmaceuticals market research reports and industry analysis

< prev 1    3  4  5  6  7  8  9  10  
Sector Report Specialty Pharmaceuticals Industry
4/16/2014 | published by: Bourne Capital Partners, L.L.C.
... continue to increase. Industry growth is anticipated to continue as is merger and acquisition volume. Bourne Partners Specialty Pharmaceuticals Industry Sector Report offers unique insight into industry trends and trading and transaction comparables from across ...  |  read more...
$495.00
Depomed, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Depomed, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
$350.00
Alnylam Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Alnylam Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
$350.00
Elder Pharmaceuticals, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Elder Pharmaceuticals, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
$350.00
Kyowa Hakko Kirin Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Kyowa Hakko Kirin Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes ...  |  read more...
$350.00
Ranbaxy Laboratories Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Ranbaxy Laboratories Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
$350.00
GlaxoSmithKline Biologicals S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' GlaxoSmithKline Biologicals S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
$350.00
BioGaia AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' BioGaia AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
$350.00
Gedeon Richter Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Gedeon Richter Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
$350.00
Organon BioSciences N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Organon BioSciences N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
$350.00
Recipharm AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Recipharm AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
$350.00
Otsuka Holdings Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Otsuka Holdings Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, ...  |  read more...
$350.00
Rigel Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Rigel Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
$350.00
QRxPharma Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' QRxPharma Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
$350.00
Cornerstone Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Cornerstone Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
$350.00
EUSA Pharma, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' EUSA Pharma, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
$350.00
Impax Laboratories, Inc. (formerly Global Pharmaceutical Corporation) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Impax Laboratories, Inc. (formerly Global Pharmaceutical Corporation) Mergers & Acquisitions (M&A), Partnerships & Alliances ...  |  read more...
$350.00
Amarin Corporation plc (formerly Ethical Holdings plc) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Amarin Corporation plc (formerly Ethical Holdings plc) Mergers & Acquisitions (M&A), Partnerships & Alliances ...  |  read more...
$350.00
Omega Pharma NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Omega Pharma NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
$350.00
Regulus Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Regulus Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
$350.00
Capsugel Belgium BVBA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Capsugel Belgium BVBA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
$350.00
Endo Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Endo Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
$350.00
United Drug Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' United Drug Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
$350.00
Isis Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Isis Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
$350.00
Advanced Cell Technology, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Advanced Cell Technology, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, ...  |  read more...
$350.00
< prev 1    3  4  5  6  7  8  9  10  
 
Our Clients